Intravitreal bevacizumab for treatment of serous macular detachment in central retinal vein occlusion


Cinal A., Ziemssen F., Bartz-Schmidt K. U. , Gelisken F.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, vol.249, no.4, pp.513-520, 2011 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 249 Issue: 4
  • Publication Date: 2011
  • Doi Number: 10.1007/s00417-010-1551-2
  • Journal Name: GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.513-520

Abstract

Purpose To report the long-term effect of intravitreal bevacizumab on serous macular detachment (SMD) in central retinal vein occlusion (CRVO).